Symbols / IMGN
IMGN Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock? - Yahoo Finance Fri, 09 Feb 2024 08
- ImmunoGen (IMGN) Stock Down Despite Q2 Earnings & Sales Beat - Nasdaq ue, 01 Aug 2023 07
- Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on - Fierce Pharma ue, 02 Jan 2024 08
- Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion - CNBC hu, 30 Nov 2023 08
- AbbVie's $10.1 billion deal to buy ImmunoGen values the stock at a 95% premium - MarketWatch hu, 30 Nov 2023 08
- Analyzing The Acquisition Potential Of ImmunoGen (NASDAQ:IMGN) - Seeking Alpha ue, 31 Oct 2023 07
- Here's Why ImmunoGen Inc. Fell 9.2% Today - The Motley Fool hu, 07 Jun 2018 07
- ImmunoGen Finalizes Merger, Amends Operations, and Delists Shares - TipRanks Mon, 12 Feb 2024 08
- ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock - Business Wire hu, 04 May 2023 07
- AbbVie seeks lift from 'guided missile' cancer drug with $10 bln ImmunoGen deal - Reuters hu, 30 Nov 2023 08
- ImmunoGen (IMGN) Stock Surges 230% in a Month: Here's Why - Yahoo Finance Fri, 12 May 2023 07
- Here's Why You Should Add ImmunoGen (IMGN) to Your Portfolio Now - Nasdaq Fri, 19 May 2023 07
- AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why - The Motley Fool ue, 26 Dec 2023 08
- How ImmunoGen (IMGN) Stock Stands Out in a Strong Industry - Yahoo Finance ue, 09 Jan 2024 08
- Immunogen (IMGN) Price Target Increased by 35.04% to 31.68 - Nasdaq Fri, 15 Dec 2023 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for IMGN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|